Issue 8, 2017
From the journal:

Chemical Science

Correction: Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

M. A. Rajora,ab   L. Ding,a   M. Valic,ab   W. Jiang,a   M. Overchuk,ab   J. Chena  and  G. Zheng*abc  

* Corresponding authors

a Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, Canada
E-mail: gzheng@uhnresearch.ca

b Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Canada

c Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, Canada

Abstract

Correction for ‘Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma’ by M. A. Rajora et al., Chem. Sci., 2017, DOI: 10.1039/c7sc00732a.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C7SC90047C
Article type
Correction
Submitted
06 Jul 2017
Accepted
06 Jul 2017
First published
13 Jul 2017
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY license

Chem. Sci., 2017,8, 5803-5803

Permissions

Request permissions

Correction: Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

M. A. Rajora, L. Ding, M. Valic, W. Jiang, M. Overchuk, J. Chen and G. Zheng, Chem. Sci., 2017, 8, 5803 DOI: 10.1039/C7SC90047C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements